Y-mAbs Therapeutics Inc (YMAB)
12.92
+0.07
(+0.54%)
USD |
NASDAQ |
May 23, 12:23
Y-mAbs Therapeutics Price to Book Value: 5.716 for May 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 22, 2024 | 5.685 |
| May 21, 2024 | 5.557 |
| May 20, 2024 | 5.229 |
| May 17, 2024 | 5.132 |
| May 16, 2024 | 5.243 |
| May 15, 2024 | 5.389 |
| May 14, 2024 | 5.229 |
| May 13, 2024 | 5.393 |
| May 10, 2024 | 5.433 |
| May 09, 2024 | 5.694 |
| May 08, 2024 | 6.021 |
| May 07, 2024 | 7.614 |
| May 06, 2024 | 7.627 |
| May 03, 2024 | 7.587 |
| May 02, 2024 | 7.632 |
| May 01, 2024 | 7.295 |
| April 30, 2024 | 6.729 |
| April 29, 2024 | 6.856 |
| April 26, 2024 | 6.506 |
| April 25, 2024 | 6.564 |
| April 24, 2024 | 6.763 |
| April 23, 2024 | 6.785 |
| April 22, 2024 | 6.706 |
| April 19, 2024 | 6.692 |
| April 18, 2024 | 6.632 |
| Date | Value |
|---|---|
| April 17, 2024 | 6.680 |
| April 16, 2024 | 6.694 |
| April 15, 2024 | 6.592 |
| April 12, 2024 | 6.353 |
| April 11, 2024 | 6.468 |
| April 10, 2024 | 6.097 |
| April 09, 2024 | 6.220 |
| April 08, 2024 | 6.388 |
| April 05, 2024 | 6.393 |
| April 04, 2024 | 6.437 |
| April 03, 2024 | 6.375 |
| April 02, 2024 | 6.526 |
| April 01, 2024 | 7.158 |
| March 31, 2024 | |
| March 28, 2024 | 7.049 |
| March 27, 2024 | 7.153 |
| March 26, 2024 | 6.806 |
| March 25, 2024 | 6.810 |
| March 22, 2024 | 7.036 |
| March 21, 2024 | 7.344 |
| March 20, 2024 | 6.715 |
| March 19, 2024 | 6.455 |
| March 18, 2024 | 5.965 |
| March 15, 2024 | 6.372 |
| March 14, 2024 | 6.502 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.132
Minimum
Mar 22 2023
19.98
Maximum
Jan 11 2021
6.528
Average
5.672
Median
Price to Book Value Benchmarks
| The Cooper Companies Inc | 2.463 |
| Puma Biotechnology Inc | 3.908 |
| Humacyte Inc | 33.72 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 19.83 |
Price to Book Value Related Metrics
| PS Ratio | 6.678 |
| Price | 12.92 |
| Earnings Yield | -3.79% |
| Market Cap | 566.96M |